Search - tctmd.com

Displaying 281 - 300 of 529

Sort: Relevancy | Date

Presentation THT 2025

When to Use Devices the Recude Renal Vein Pressure

Presenter: Liviu Klein

February 12, 2025

Presentation THT 2025

When to Use an Invasive Device That Removes Fluid From the Extracellular Space

Presenter: William Abraham

February 12, 2025

Presentation THT 2025

When to Use a Noninvasive Device That Remove Fluid From the Extracellular Space

Presenter: Daniel Bensimhon

February 12, 2025

Presentation THT 2025

When to Use a Form of Replacement Therapies

Presenter: Maria Rosa Costanzo

February 12, 2025

Presentation THT 2025

When and Why Are Diuretics Sometimes Just Not Enough?

Presenter: Jennifer Cowger

February 12, 2025

Presentation THT 2025

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Presenter: Marco Metra

February 12, 2025

Presentation THT 2025

Valvular Interventions in a Patient With Severe PH

Presenter: Estefania Oliveros

February 12, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Presenter: Beth Davison

February 12, 2025

Presentation THT 2025

Sotatercept in Contemporary PAH Treatment Algorithm

Presenter: Thomas Cascino

February 12, 2025

Presentation THT 2025

Remote Monitoring in PH: Where We Are and Where We Need to Go

Presenter: Sophia Airhart

February 12, 2025

Presentation THT 2025

Pulmonary Artery Denervation for PH: Ready for Primetime?

Presenter: Greg Lewis

February 12, 2025

Presentation THT 2025

Pressure-Volume Loop Derived Left Ventricular Hypercontractility Is Associated With Reduced Long-Term Survival in Heart Failure With Preserved Ejection Fraction

Presenter: Sebastian Roschx

February 12, 2025

Presentation THT 2025

PA Counter-Pulsation

Presenter: Jane Leopold

February 12, 2025

Presentation THT 2025

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Presenter: Javed Butler

February 12, 2025

Presentation THT 2025

Inflammation as a Target in Acute HF

Presenter: Gad Cotter

February 12, 2025

Presentation THT 2025

Inflammation and HFpEF: Rationale for HERMES

Presenter: Mark Petrie

February 12, 2025

Presentation THT 2025

Impact of SGLT2 Inhibitors on Mortality and Cardiovascular Admissions in Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 12, 2025

Presentation THT 2025

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Presenter: Barry Borlaug

February 12, 2025

Presentation THT 2025

HFpEF Hidden in Plain Sight: Undertreatment of Patients With Negative Screening for Suspected Amyloidosis

Presenter: Solenn Dal Soglio

February 12, 2025

Presentation THT 2025

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Presenter: Milton Packer

February 12, 2025

Advertisement

When to Use Devices the Recude Renal Vein Pressure

When to Use an Invasive Device That Removes Fluid From the Extracellular Space

When to Use a Noninvasive Device That Remove Fluid From the Extracellular Space

When to Use a Form of Replacement Therapies

When and Why Are Diuretics Sometimes Just Not Enough?

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Valvular Interventions in a Patient With Severe PH

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Sotatercept in Contemporary PAH Treatment Algorithm

Remote Monitoring in PH: Where We Are and Where We Need to Go

Pulmonary Artery Denervation for PH: Ready for Primetime?

Pressure-Volume Loop Derived Left Ventricular Hypercontractility Is Associated With Reduced Long-Term Survival in Heart Failure With Preserved Ejection Fraction

PA Counter-Pulsation

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Inflammation as a Target in Acute HF

Inflammation and HFpEF: Rationale for HERMES

Impact of SGLT2 Inhibitors on Mortality and Cardiovascular Admissions in Heart Failure With Reduced Ejection Fraction (HFrEF)

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

HFpEF Hidden in Plain Sight: Undertreatment of Patients With Negative Screening for Suspected Amyloidosis

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content